Invesco CurrencyShares Euro Trust Files Quarterly Report (10-Q)

TL;DR

<b>Invesco CurrencyShares Euro Trust filed its Q1 2024 10-Q report, detailing operations and financial status.</b>

AI Summary

Invesco CurrencyShares Euro Trust (FXE) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. The Invesco CurrencyShares Euro Trust filed a 10-Q report for the quarterly period ended March 31, 2024. The Trust's common units of beneficial interest trade under the symbol FXE on the NYSE Arca. The filing covers the period from January 1, 2024, to March 31, 2024. The registrant's principal executive offices are located at 3500 Lacey Road, Suite 700, Downers Grove, Illinois. The Trust is sponsored by Invesco Specialized Products, LLC.

Why It Matters

For investors and stakeholders tracking Invesco CurrencyShares Euro Trust, this filing contains several important signals. This filing provides investors with the latest financial performance and operational details of the Euro Trust, crucial for understanding its current standing and future prospects. As a trust tracking the Euro, this report offers insights into the currency's performance relative to other assets and the broader market conditions influencing it.

Risk Assessment

Risk Level: low — Invesco CurrencyShares Euro Trust shows low risk based on this filing. The filing is a standard quarterly report (10-Q) for a well-established trust, indicating routine operations with no immediate high-risk indicators.

Analyst Insight

Monitor the trust's net asset value and any commentary on Euro performance in future filings to assess investment suitability.

Key Numbers

• 2024-03-31 — Quarterly Period End Date (The report covers the period ending on this date.)
• 2024-05-08 — Filing Date (The date the 10-Q was filed with the SEC.)
• 001-32694 — SEC File Number (Commission File Number for the registrant.)

Key Players & Entities

• Invesco CurrencyShares Euro Trust (company) — Registrant name
• FXE (company) — Trading Symbol
• NYSE Arca (company) — Exchange
• Invesco Specialized Products, LLC (company) — Sponsor
• March 31, 2024 (date) — Quarterly period ended
• 2024-05-08 (date) — Filing date

FAQ

Industry Context

The Invesco CurrencyShares Euro Trust is a financial instrument designed to track the performance of the Euro currency against the US Dollar.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Section 13 or 15(d), requiring quarterly reports.

What Investors Should Do

1. Review the full 10-Q filing for detailed financial statements and management discussion.
2. Analyze the trust's net asset value and share performance in relation to Euro exchange rate movements.
3. Compare the trust's performance against its benchmark (the Euro) and other currency ETFs.

Key Dates

• 2024-03-31: Quarterly Period End — Marks the end of the reporting period for the 10-Q.
• 2024-05-08: Filing Date — Date the 10-Q was officially submitted to the SEC.

Year-Over-Year Comparison

This is the standard quarterly report for the period ending March 31, 2024, following previous filings.

Filing Documents

• fxe-20240331.htm (10-Q) — 510KB
• fxe-ex31_1.htm (EX-31.1) — 14KB
• fxe-ex31_2.htm (EX-31.2) — 15KB
• fxe-ex32_1.htm (EX-32.1) — 10KB
• fxe-ex32_2.htm (EX-32.2) — 10KB
• img174612315_0.jpg (GRAPHIC) — 202KB
• img174612315_1.jpg (GRAPHIC) — 257KB
• img174612315_2.jpg (GRAPHIC) — 169KB
• 0000950170-24-054974.txt (&nbsp;) — 3302KB
• fxe-20240331.xsd (EX-101.SCH) — 296KB
• fxe-20240331_htm.xml (XML) — 146KB

Financial Statements

Financial Statements 1 Notes to Unaudited Financial Statements 6 ITEM 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 10 ITEM 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 13 ITEM 4.

Controls and Procedures

Controls and Procedures 13 PART II. OTHER INFORMATION 14 Item 1.

Legal Proceedings

Legal Proceedings 14 Item 1A.

Risk Factors

Risk Factors 14 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 14 Item 3. Defaults Upon Senior Securities 14 Item 4. Mine Safety Disclosures 14 Item 5. Other Information 14 Item 6. Exhibits 14

– FINA NC IAL INFORMATION

PART I – FINA NC IAL INFORMATION

Fi na ncial Statements

Item 1. Fi na ncial Statements. Invesco CurrencyShares Euro Trust March 31, 2024 and December 31, 2023 (Unaudited) March 31, 2024 December 31, 2023 Assets Euro deposits, interest bearing $ 199,288,526 $ 214,030,570 Subscriptions receivable — 5,095,966 Cash due from Depository 371,721 154,445 Receivable from accrued interest 475,303 505,646 Total Assets $ 200,135,550 $ 219,786,627 Liabilities Euro deposits, non-interest bearing, overdrawn $ 383,115 $ 152,031 Accrued Sponsor's fee 69,655 73,957 Total Liabilities 452,770 225,988 Commitments and Contingent Liabilities (Note 8) Redeemable Capital Shares and Shareholders' Equity Redeemable Capital Shares, at redemption value, no par value, 2,000,000 and 2,150,000 issued and outstanding, respectively 199,682,780 219,560,639 Shareholders' Equity: Retained Earnings — — Total Liabilities, Redeemable Capital Shares and Shareholders' Equity $ 200,135,550 $ 219,786,627 See accompanying Notes to Unaudited Financial Statements which are an integral part of the financial statements. 1 Invesco CurrencyShares Euro Trust For the Three Months Ended March 31, 2024 and 2023 (Unaudited) Three Months Ended March 31, 2024 2023 Income Interest Income $ 1,423,562 $ 910,525 Total Income 1,423,562 910,525 Expenses Sponsor's fee ( 207,935 ) ( 284,778 ) Interest Expense on currency deposits — — Total Expenses ( 207,935 ) ( 284,778 ) Net Comprehensive Income (Loss) $ 1,215,627 $ 625,747 Basic and Diluted Earnings (Loss) per Share $ 0.58 $ 0.22 Weighted-average Shares Outstanding 2,079,670 2,905,556 See accompanying Notes to Unaudited Financial Statements which are an integral part of the financial statements. 2 Invesco CurrencyShares Euro Trust

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations. Cautionary Statement Regarding Forward-Looking Information This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "outlook" and "estimate" and other similar words. Forward-looking statements are based upon our current expectations and beliefs concerning future developments and their potential effects on us. Such forward-looking statements are not guarantees of future performance. Various factors may cause our actual results to differ materially from those expressed in our forward-looking statements. These factors include fluctuations in the price of the euro, as the value of the Shares relates directly to the value of the euro held by the Trust and price fluctuations could materially adversely affect an investment in the Shares. Readers are urged to review the "Risk Factors" section contained in the Trust's most recent annual report on Form 10-K for a description of other risks and uncertainties that may affect an investment in the Shares. Neither Invesco Specialized Products, LLC (the "Sponsor") nor any other person assumes responsibility for the accuracy or completeness of forward-looking statements contained in this report. The forward-looking statements are made as of the date of this report, and will not be revised or updated to reflect actual results or changes in the Sponsor's expectations or predictions. Overview/Introduction The Invesco CurrencyShares Euro Trust (the "Trust") is a grantor trust that was formed on December 5, 2005. The Shares began trading on the New York Stock Exchange under the ticker symbol "FXE" on December 12, 2005. The primary listing of the Shares was transferred to NYSE Arca, Inc. ("NYSE Arca") on October 30, 2007. The Trust issues shares (th

View Full Filing

View this 10-Q filing on SEC EDGAR